AD Ormerod

787 citations
9 papers · 667 · h-index 4

Impact in

  • Immunology top 5%
    • Psoriasis: Treatment and Pathogenesis
    • Dermatology and Skin Diseases
    • Dermatological and COVID-19 studies

Papers in

    • Dermatology and Skin Diseases 4
    • Medicine and Dermatology Studies History 1
    • Dermatological and COVID-19 studies 1
    • Psoriasis: Treatment and Pathogenesis 4

AD Ormerod

9 papers receiving 638 citations

Peers

AD Ormerod
Comparison fields: 5 of 53
  • Immunology 503
  • Dermatology 66
  • Rheumatology 41
  • Pharmaceutical Science 15
  • Toxicology 9
Replace Natalie Reytan with:
Natalie Reytan Germany
J.M. Carrascosa Spain
Wouter F.M. Goldschmidt Netherlands
Manuel Sánchez-Regaña Spain
Gayle E. van der Kraaij Netherlands
Tarja Mälkönen Finland
Judit Nyirady United States
S A Muller Germany
Carolyn Hughes United Kingdom
AD Cohen Israel
AD Ormerod relative to Natalie Reytan Germany Natalie Reytan's profile →
Citations per field
00.5×1.7×
Natalie Reytan · 1×
Citations per year

Countries citing papers authored by AD Ormerod

Since Specialization
Citations

This map shows the geographic impact of AD Ormerod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AD Ormerod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AD Ormerod more than expected).

Fields of papers citing papers by AD Ormerod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AD Ormerod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AD Ormerod. The network helps show where AD Ormerod may publish in the future.

Co-authors

The 18 scholars most cited alongside AD Ormerod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with AD Ormerod Line = papers co-authored together AD Ormerod links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 2009599
2 200927
3 200724
4 20087
5 19924
6
Pimecrolimus cream 1% once-daily maintenance therapy for the prevention of relapse in mild to moderate dermatitis in adults.
20052
7
Persistence with biologic therapies for the treatment of moderate to severe psoriasis: a prospective observational study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
20142
8 19891
9 19981

About AD Ormerod

AD Ormerod is a scholar working on Dermatology, Immunology, Pharmaceutical Science, Pharmacology and Public Health, Environmental and Occupational Health, having authored 9 papers that have together received 667 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Advancements in Transdermal Drug Delivery (2 papers), Medicine and Dermatology Studies History (1 paper), Drug-Induced Adverse Reactions (1 paper), Dermatological and COVID-19 studies (1 paper) and Clinical practice guidelines implementation (1 paper). The work is most often cited by research in Immunology (503 citations), Dermatology (66 citations), Rheumatology (41 citations), Pharmaceutical Science (15 citations) and Toxicology (9 citations). AD Ormerod has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Sanjay M Rajpara, Catherine Smith, Berthold Rzany, Alexander Nast, Natalie Reytan, Phyllis Ira Spuls, A.J. Winfield, Aroonsri Priprem, Richard Bruce Warren and Zenas Z N Yiu. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, Journal of Dermatological Treatment, British Journal of Dermatology, Journal of Investigative Dermatology and Scottish Medical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact